Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A: a systematic review, a pairwise and network meta-analysis of randomized controlled trials

[31] Duclos M(2002)Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial Lancet. 359 1187-1575

[32] Braun J(2005)Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT) Arthritis Rheum 52 582-954

[33] Baraliakos X(2005)Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study Ann Rheum Dis 64 1568-1210

[34] Listing J(2009)Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis Arthritis Rheum 60 946-107

[35] Sieper J(2010)A double-blind, placebo-controlled trial of low dose infliximab in ankylosing spondylitis J Rheumatol 37 1203-1440

[36] Lie E(2014)Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, part 1 Ann Rheum Dis 73 101-1356

[37] Lindström U(2010)A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis Rheumatol Int 30 1437-3236

[38] Zverkova-Sandström T(2002)Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha N Engl J Med 346 1349-1675

[39] Olsen IC(2003)Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial Arthritis Rheum 48 3230-1600

[40] Forsblad-d'Elia H(2003)Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis Arthritis Rheum 48 1667-1577

[31] Duclos M(2002)Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial Lancet. 359 1187-1575

[32] Braun J(2005)Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT) Arthritis Rheum 52 582-954

[33] Baraliakos X(2005)Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study Ann Rheum Dis 64 1568-1210

[34] Listing J(2009)Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis Arthritis Rheum 60 946-107

[35] Sieper J(2010)A double-blind, placebo-controlled trial of low dose infliximab in ankylosing spondylitis J Rheumatol 37 1203-1440

[36] Lie E(2014)Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, part 1 Ann Rheum Dis 73 101-1356

[37] Lindström U(2010)A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis Rheumatol Int 30 1437-3236

[38] Zverkova-Sandström T(2002)Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha N Engl J Med 346 1349-1675

[39] Olsen IC(2003)Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial Arthritis Rheum 48 3230-1600

[40] Forsblad-d'Elia H(2003)Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis Arthritis Rheum 48 1667-1577